Examkin

Soru

Zorluk: ZorGynecologic Oncology

A 47-year-old G2P2 patient presents to the clinic for her annual preventive health visit. She feels well and reports no pelvic pain, vaginal discharge, or abnormal bleeding. Her menstrual cycles remain regular, occurring every 29 days with 5 days of normal flow. Her last menstrual period ended two weeks ago. Medical history is unremarkable, and she takes no medications. Vital signs are normal. Speculum examination reveals a normal, parous cervix without visible lesions. Bimanual examination demonstrates a mobile, non-enlarged uterus and no adnexal masses. A sample obtained for cervical cancer screening shows "negative for intraepithelial lesion or malignancy" with the presence of "benign endometrial cells." Concurrent testing for high-risk human papillomavirus (HPV) is negative. Which of the following is the most appropriate next step in the care of this patient?

  1. Endometrial biopsyCevap
  2. B
    Colposcopy with endocervical curettage
  3. C
    Routine cervical cancer screening in 5 years
  4. D
    Transvaginal ultrasonography
  5. E
    Repeat cervical cytology in 12 months

Cevap

Endometrial biopsy
The most appropriate next step in management is an endometrial biopsy. According to guidelines from the American Society for Colposcopy and Cervical Pathology (ASCCP) and the American College of Obstetricians and Gynecologists (ACOG), the presence of benign endometrial cells on cervical cytology in women aged 45 years and older requires direct endometrial evaluation. While it is normal for premenopausal women to shed endometrial cells during the first half of their menstrual cycle, this finding becomes increasingly associated with endometrial hyperplasia or carcinoma as women age. Therefore, the age cutoff of 45 was established to ensure that potential uterine malignancies are not missed, regardless of the patient's menopausal status, symptom profile, or the specific day of her menstrual cycle. The negative HPV test and lack of cervical dysplasia indicate that her risk for cervical cancer is low, but the endometrial cavity must still be sampled.

Adım Adım Çözüm

1
Analyze the patient's demographic and clinical presentation.
The patient is a 47-year-old premenopausal woman with regular cycles and an asymptomatic presentation.
Age is a critical determinant in the management of incidental findings on cervical cytology.
2
Evaluate the cervical cytology and HPV testing results.
The Pap test is negative for dysplasia but shows benign endometrial cells. The HPV test is negative.
Cytology results dictate the next step in the cervical cancer screening algorithm.
3
Apply clinical guidelines for the specific cytology finding.
According to ASCCP and ACOG guidelines, the presence of endometrial cells on cytology in any woman aged 45 years or older necessitates an endometrial biopsy.
Shedding of endometrial cells in this age group carries a higher risk of underlying endometrial hyperplasia or cancer, even if the cells appear benign and the patient is asymptomatic.

Anahtar Kavram

Women aged 45 years and older who have benign endometrial cells reported on cervical cytology require an endometrial biopsy, regardless of their menopausal status or the presence of symptoms.
Tahmini Süre:1m 30s
Bu soruyu puanla

Konular

Gynecologic Oncology

Bu konudan daha fazla soru